Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;33(1):5-6.
doi: 10.1038/s41431-024-01655-2. Epub 2024 Jul 23.

Are employees ready to engage in genetic cancer risk assessment in the workplace setting?

Isabelle R Chandler  1 , Jesse T Brewer  2 , Muhammad Danyal Ahsan  2 , Tamar Nicole Soussana  2 , Emily M Webster  2 , Michelle Primiano  2 , Ravi N Sharaf  2 , Melissa K Frey  2
Affiliations

Are employees ready to engage in genetic cancer risk assessment in the workplace setting?

Isabelle R Chandler et al. Eur J Hum Genet. 2025 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 2.2024). NCCN Clinical Practice Guidelines in Oncology. 2024 https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf. - PubMed
    1. Sessa C, Balmana J, Bober SL, Cardoso MJ, Colombo N, Curigliano G, et al. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol. 2023;34:33–47. - PubMed
    1. Webster EM, Ahsan MD, McDougale A, Sharaf RN, Frey MK. Implementation of a smartphone survey and mainstreaming for genetic cancer risk assessment in a diverse, urban Medicaid-predominant gynecology clinic: A step towards health equity. Am J Obstet Gynecol. 2024;230:e108–e109. - PubMed
    1. Drohan B, Roche CA, Cusack JC Jr, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012;19:1732–7. - PubMed
    1. Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg. 2016;212:660–9. - PubMed

LinkOut - more resources